Commercialization, patents and moral assessment of biotechnology products.
The biotechnology patent debates have revealed deep moral concerns about basic genetics research, R&D and specific biotechnological products, concerns that are seldom taken into consideration in Technology Assessment. In this paper important moral concerns are examined which appear at the various stages of development of a specific genetic product: a predictive genetic test. The purpose is to illustrate the need for a more contextual approach in technology assessment, which integrates the various forms of interaction between bio-technology and society or societal segments. Such an approach will generate greater insight in the moral issues at all stages of a product's life-cycle and this will facilitate decision-making on the 'morality' of a specific biotechnological product.
Hoedemaekers
R
R
Department of Ethics, Philosophy and History of Medicine, University Medical Center, Nijmegen, Netherlands. r.hoedemaekers@efg.kun.nl
D001709:Biotechnology / Q000191:economics*; D003132:Commerce; D005060:Europe; D036281:Genetic Research; D005820:Genetic Testing / Q000191:economics*; D006801:Humans; D009014:Morals; D010330:Patents as Topic; D012945:Social Values; D013673:Technology Assessment, Biomedical / Q000379:methods*